Simon Fraser University
Engaging the World

CIHR-IG is pleased to be partnering with Ataxia Canada, Cystic Fibrosis Canada and approximately 20 international funding organizations in the context of this European Joint Programme on Rare Diseases (EJP RD) call for proposals 2023. CIHR-IG is committed to expanding and improving the diagnosis and treatment of rare diseases by creating the conditions needed to bring together creative, dynamic, interdisciplinary teams of researchers from across Canada and the European Community (EC) to collaborate for better health outcome for the rare disease patient community. The topic of the call is natural history studies addressing unmet needs in rare diseases.

Phase II of the Joint Canada-Israel Health Research Program (the Program) seeks to support fundamental research at the cutting-edge of biomedical science and global health. This first call for proposals under phase II is directed toward proposals at the intersection between non-communicable chronic disease (NCD) and infectious diseases while strengthening capacity in Canada, Israel and in low and middle income countries (LMIC).

Phase II of the Joint Canada-Israel Health Research Program (the Program) seeks to support fundamental research at the cutting-edge of biomedical science and global health. This first call for proposals under phase II is directed toward proposals at the intersection between non-communicable chronic disease (NCD) and infectious diseases while strengthening capacity in Canada, Israel and in low and middle income countries (LMIC).

Planning and Dissemination Grants are intended to provide support for planning and/or dissemination activities consistent with the mandate of CIHR and relevant to CIHR Institutes or Initiatives.

The Project Grant program is designed to capture ideas with the greatest potential for important advances in fundamental or applied health-related knowledge, health care, health systems, and/or health outcomes by supporting projects of research proposed and conducted by individual researchers or groups of researchers in all areas of health. The best ideas may stem from new, incremental, innovative, and/or high-risk lines of inquiry or knowledge translation approaches.

CIHR-IG is pleased to be partnering with Ataxia Canada, Cystic Fibrosis Canada and approximately 20 international funding organizations in the context of this European Joint Programme on Rare Diseases (EJP RD) call for proposals 2023. CIHR-IG is committed to expanding and improving the diagnosis and treatment of rare diseases by creating the conditions needed to bring together creative, dynamic, interdisciplinary teams of researchers from across Canada and the European Community (EC) to collaborate for better health outcome for the rare disease patient community. The topic of the call is natural history studies addressing unmet needs in rare diseases.

This funding opportunity is a one-year grant to catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how the biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact in both maintaining health and in the development of disease and disability as people age.

The Project Grant program is designed to capture ideas with the greatest potential for important advances in fundamental or applied health-related knowledge, health care, health systems, and/or health outcomes by supporting projects of research proposed and conducted by individual researchers or groups of researchers in all areas of health. The best ideas may stem from new, incremental, innovative, and/or high-risk lines of inquiry or knowledge translation approaches.

This funding opportunity supports research to inform standards specific to mental health and/or substance use health services for children, youth, and young adults (ages 0 to 25), including the perinatal period.

The INMD Training and Community Support Grant will support INMD research communities, including researchers and Partner Organizations, to build training programs in research domains largely and directly relevant to the Institute's mandate. INMD will fund a total of two grants with a maximum amount of $50,000 for a single grant.

This funding opportunity supports proposals that advance health knowledge through the analysis of existing large cohort, survey and/or administrative datasets.

The Operating Grants in Diabetes, Psychosocial Health, Prevention and Self-Management will support research into approaches that will build on successful models of care, knowledge mobilization, and optimization of self-management.

The THINC Implementation Science Team Grants will support interdisciplinary research teams dedicated to understanding the implementation, evaluation, adaptation, and/or and spread/scale of transformative evidence-informed integrated care policies and interventions that will advance the Quadruple Aim and health equity

Recognizes exceptional contributions in the area of population and public health research.

These grants will support the creation of three networks, one each in the areas of Skin Health, Bone Health, and Muscular Dystrophy. The networks will provide research leadership, stimulate innovative research and practices, strengthen research capacity, and provide a forum engaging the research community and its partners.

Recognizes an outstanding contribution to health services and policy research, policy and/or care delivery in Canada.

This funding opportunity will support the creation of several virtual hubs to form a Pan-Canadian Women’s Health Coalition. The maximum amount per grant is up to $210,000 per year for up to 4 years, for a total of $840,000 per grant.

This funding opportunity will support projects evaluating domestic or international population-level interventions to reduce inappropriate antimicrobial use and prevent the spread of resistant pathogens in humans, animals and the environment. The maximum amount per grant is $150,000 per year for up to two years, for a total of $300,000 per grant.

The Project Grant program is designed to capture ideas with the greatest potential for important advances in fundamental or applied health-related knowledge, health care, health systems, and/or health outcomes by supporting projects of research proposed and conducted by individual researchers or groups of researchers in all areas of health. The best ideas may stem from new, incremental, innovative, and/or high-risk lines of inquiry or knowledge translation approaches.

The goal of the CIHR-ICRH/CAAIF/AZ Canada/AllerGen Emerging Researcher Awards in Allergic Asthma is to enable Canadian allergists, clinical immunologists, MD clinician scientists, and basic scientists working in translational research to pursue academic research in allergic asthma.

This opportunity is to support the establishment of a multidisciplinary platform with the research expertise to identify best practices for studying sex and age as biological variables in basic science, provide training, and promote these methods and services.

This program supports outstanding new investigators as they develop their careers as independent research scientists or clinician scientists to undertake high-quality cancer research, while in close collaboration and mentorship with established TFRI or CIHR-ICR-funded research teams

This funding opportunity supports the development and testing of innovative methodologies/designs of innovative clinical trials (iCT) that is integrated with the principles of Strategy for Patient-Oriented Research (SPOR).

This catalyst grant supports research to expand current evidence and understanding of disease prevention that will lead to future intervention studies.

Phase II of the Joint Canada-Israel Health Research Program (the Program) seeks to support fundamental research at the cutting-edge of biomedical science and global health. This first call for proposals under phase II is directed toward proposals at the intersection between non-communicable chronic disease (NCD) and infectious diseases while strengthening capacity in Canada, Israel and in low and middle income countries (LMIC).